SE0300357A
SE0300357D0
(en)
|
2003-02-10 |
2003-02-10 |
New compounds
|
MXPA04012914A
MXPA04012914A
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders.
|
NZ536600A
NZ536600A
(en)
|
2002-06-20 |
2003-06-19 |
Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
CN038144328A
CN1662521A
(en)
|
2002-06-20 |
2003-06-19 |
Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
NZ552282A
NZ552282A
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
JP2004530936A
JP4754821B2
(en)
|
2002-06-20 |
2003-06-19 |
Novel compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
PCT/SE2003/001061
WO2004000828A1
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
SG200604188-3A
SG156524A1
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
CA002486989A
CA2486989A1
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
EP07122269A
EP1897876A3
(en)
|
2002-06-20 |
2003-06-19 |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
YU111204A
RS111204A
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity,type ii diabetes and cns disorders
|
EP03760999A
EP1513828A1
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
BR0311952-1A
BR0311952A
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for treating obesity, type ii diabetes and snc disorders
|
NZ552283A
NZ552283A
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
EA200600975A
EA011581B1
(en)
|
2002-06-20 |
2003-06-19 |
Heterocyclic compounds useful for the treatment of obesity and cns disorders
|
AU2003243091A
AU2003243091A1
(en)
|
2002-06-20 |
2003-06-19 |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
EA200500054A
EA008835B1
(en)
|
2002-06-20 |
2003-06-19 |
Substituted sulfone and sulfonamides and pharmaceutical compositions based thereon useful for the treatment of obesity, type ii diabetes cns disorders
|
EP07122274A
EP1897881A3
(en)
|
2002-06-20 |
2003-06-19 |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
US10/465,034
US7943639B2
(en)
|
2002-06-20 |
2003-06-19 |
Compounds
|
IL16505104A
IL165051A0
(en)
|
2002-06-20 |
2004-11-04 |
New compounds useful for the treatment of obesity,type II diabetes and cns disorders
|
NO20050294A
NO20050294L
(en)
|
2002-06-20 |
2005-01-19 |
New compounds useful in the treatment of obesity, type II diabetes and CNS disorders
|